Nautilus Biotechnology, Inc.
NAUT
OF BUSINESS COMBINATION On June 9, 2021 (the Closing Date ), Nautilus Biotechnology, Inc., a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp III ( ARYA )), consummated the business combination (the Business Combination ) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the Business Combination Agreement ), by and among ARY…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$59M
▲ +16.6% YoY
Op. Margin
–
ROIC
–
Cash Flow & Balance Sheet
FCF (TTM)
-$55M
▲ +15.2% YoY
Op. Cash Flow (TTM)
-$52M
▲ +14.3% YoY
Net Debt
-$60M
Net Cash Position
Cash & Equiv.
$87M
Continue Research
Peers
Laboratory Analytical Instruments · Pick stocks to compare with NAUT
Held by ETFs
NAUT is in 1 US ETF. The largest of them, with NAUT's weight in each:
Nautilus Biotechnology (NAUT) in two numbers
Questions about Nautilus Biotechnology
Does Nautilus Biotechnology (NAUT) pay a dividend?
No. Nautilus Biotechnology (NAUT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 22 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in NAUT's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NAUT
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.